Cold Chain

The orphan drug will reach patients through a limited-distribution network of specialty pharmacies

Leading US provider will produce 70 million doses in next several months

Innovative device offers logistics advantages over other bulk cold-chain containers

MyCubixx technology puts an interactive refrigerator in the patient’s home

Goal is to build a template that can be used globally for supply chain visibility for healthcare

Cinven buys out previous owner, reportedly for over €1 billion

Q Products touts its blankets as an alternative to reefer containers

Total active (powered) fleet is 5,500 units

Evo 1.0 monitoring system combines with Extreme 1.5-L containers and dewars

Pharmaceutical Commerce’s annual market forecast projects 12.7% YOY growth

Proprietary processes combine cryogenic and room-temperature steps for adipose tissue

Supply chain security—with DSCSA compliance—could be a near-term use case, says Accenture

Wide capacity range combines with CRT, refrigerated and frozen shipping

Deepens focus on logistics for direct-to-patient, cell and gene therapy and clinical trials execution

Thousands of human eggs and embryos may have been lost; meanwhile, industry research facilities shift to predictive maintenance

Will also expands capacity in the EU market

Absorption into HDA will add resources

RAP unit adds to vendor choices for air cargo containers

Savsu’s evo DV containers will be available through World Courier’s 140 offices

wo UK companies join forces for pharma cold chain

The appearance of deep-frozen products will complicate distribution practices

Multi-vendor Team-Up approach should ease systems integration

Said to be industry’s first for combined EU, USP and WHO standards

Latest report tracks growth of specialty sector shows a jump in exclusive distribution

American Academy of Pediatrics updates its cord blood banking guidance

The station is part of a strategic US growth plan

Libero ITS provides both indication and datalogging

Vendors continue to bring new products and services to the life sciences cold chain

US’ Great Point Partners funds the private-equity deal